Rosetta Genomics Ltd. (NASDAQ: ROSG) announces conditional approval status for RosettaGX Reveal™, its novel microRNA classifier for the diagnosis of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE